Chromenone indoles

Details for Australian Patent Application No. 2004226279 (hide)

Owner Merck Patent GmbH

Inventors Van Amsterdam, Christoph; Leibrock, Joachim; Heinrich, Timo; Schiemann, Kai; Seyfried, Christoph; Bottcher, Henning; Holzemann, Gunter; Bartoszyk, Gerd

Agent Davies Collison Cave

Pub. Number AU-B-2004226279

PCT Pub. Number WO2004/087692

Priority 103 15 285.7 04.04.03 DE

Filing date 8 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 28 October 2010

International Classifications

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

24 November 2005 PCT application entered the National Phase

  PCT publication WO2004/087692 Priority application(s): WO2004/087692

28 October 2010 Application Accepted

  Published as AU-B-2004226279

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226280-Method for the production of pyrrolidine-1,2-dicarboxylic acid1-(phenyl(-amide))-2-(phenyl(-amide)) derivatives and 1-(phenylcarbamoyl)-pyrrolidine-2-carb oxylic acid derivatives as intermediate products

2004226278-Pyrrolidino1,2-dicarboxy-1-(phenylamide)-2-(4-(3oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor Xa in the treatment of thrombo-embolic diseases